Research into CDK8 oncogene could improve design of future therapeutics
A study has shown that type II kinase inhibitors targeting…
A study has shown that type II kinase inhibitors targeting CDK8 alone are ineffective because mutations leave them inactive, suggesting future therapies should target CDK8 in complex.